Antithrombotic strategies after transcatheter aortic valve implantation: Insights from a network meta-analysis.
Toshiki KunoHisato TakagiTakehiro SugiyamaTomo AndoSatoshi MiyashitaNelson ValentinYuichi J ShimadaMasaki KodairaYohei NumasawaYumiko KaneiKentaro HayashidaSripal BangalorePublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)
Patients who underwent TAVI had similar all-cause mortality rates among different antithrombotic strategies except OAC+DAPT. Patients on SAPT had significantly lower bleeding risk than those on DAPT, OAC + SAPT, and OAC + DAPT. Our results suggest SAPT is the preferred regimen when there is no indication for DAPT or OAC. When DAPT or OAC is indicated, DAPT + OAC should be avoided.
Keyphrases
- antiplatelet therapy
- transcatheter aortic valve implantation
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- atrial fibrillation
- aortic stenosis
- aortic valve
- peritoneal dialysis
- prognostic factors
- percutaneous coronary intervention
- acute coronary syndrome
- aortic valve replacement
- coronary artery disease
- left ventricular
- transcatheter aortic valve replacement
- patient reported outcomes
- patient reported